Discontinue Semaglutide Immediately
A urticarial rash after the second dose of semaglutide represents a hypersensitivity reaction requiring immediate and permanent discontinuation of the medication 1. This is a drug-induced urticaria that typically occurs within 24 hours of drug administration and indicates an allergic response 2.
Immediate Management Steps
Stop semaglutide permanently. Do not attempt rechallenge, as hypersensitivity reactions can worsen with repeated exposure 3.
Symptomatic Treatment
- Start a non-sedating H1-antihistamine immediately (cetirizine, loratadine, fexofenadine, or desloratadine once daily) 4
- Offer the patient at least two different H1-antihistamine options, as individual responses vary 4
- If inadequate response after 1-2 weeks, increase the antihistamine dose up to 4 times the standard dose (off-label but commonly practiced) 4
- Consider adding an H2-antihistamine (ranitidine or famotidine) for additional urticaria control 4
- For severe reactions with angioedema or systemic symptoms: add oral corticosteroids (prednisone 40-60 mg daily for 3-5 days) 3
Monitor for Progression
Watch closely for:
- Angioedema (facial, lip, or tongue swelling)
- Respiratory symptoms (wheezing, dyspnea)
- Systemic symptoms suggesting anaphylaxis
- Any blistering or mucosal involvement (would suggest more severe drug reaction)
If any of these develop, treat as anaphylaxis with epinephrine and emergency care 2.
Alternative Diabetes/Weight Management
Do not switch to another GLP-1 receptor agonist. While cross-reactivity data is limited, case reports document hypersensitivity reactions across the GLP-1RA class (dulaglutide, liraglutide, semaglutide) 5, 6. The risk of cross-reaction is substantial enough to avoid the entire class 7.
Consider alternative agents:
- SGLT2 inhibitors if cardiorenal protection is needed (empagliflozin, dapagliflozin, canagliflozin) 7
- Metformin as first-line if not already prescribed
- DPP-4 inhibitors (though less effective for weight loss)
- Phentermine-topiramate ER for weight management if no cardiovascular contraindications 8
Documentation and Patient Education
Document the reaction clearly as "semaglutide hypersensitivity - urticarial rash" in the allergy list to prevent future prescribing 3.
Educate the patient to:
- Inform all healthcare providers about this drug allergy
- Avoid all GLP-1 receptor agonists (semaglutide, dulaglutide, liraglutide, tirzepatide, exenatide)
- Report immediately if urticaria worsens or new symptoms develop
- Continue antihistamines until rash completely resolves (typically 1-4 weeks)
Important Caveats
The FDA label for semaglutide notes that immunogenicity occurs in approximately 1% of patients, with anti-drug antibodies developing 1. Your patient's urticarial reaction after only the second dose suggests either IgE-mediated hypersensitivity or a reaction to an excipient (such as propylene glycol in the formulation) 6.
Do not attempt desensitization protocols - these are reserved for situations where no alternative therapy exists and the drug is life-saving (e.g., chemotherapy), which does not apply to diabetes or weight management where multiple alternatives exist 3.
The prognosis for drug-induced urticaria is excellent with drug discontinuation, with most cases resolving within days to weeks 4, 2.